Skip to main content

Table 3 Comparison of clinical indices, histopathologic factors and imaging indices between neoadjuvant therapy followed by radical hysterectomy group and concurrent chemoradiotherapy group

From: MRI outcome evaluation in patients with IB2 and IIA2 squamous cervical cancer stages: preliminary results

Index NAT + RH group (n = 86) CCRT group (n = 63) p value
Age 50.3 ± 8.7 51.9 ± 8.0 0.244
FIGO    0.683
  IB2 37 25  
  IIA2 49 38  
Pretreatment hemoglobin    0.537
  Normal 66 51  
  Abnormal 20 12  
SCC-Ag 3.1 (1.7, 6.0) 4.9 (1.8, 10.9) 0.099
MDT 45.0 (42.0, 50.0) 44.0 (41.0, 48.0) 0.277
ADCmax 1.080 ± 0.132 1.053 ± 0.117 0.205
ADCmean 0.908 ± 0.133 0.886 ± 0.117 0.296
ADCmin 0.769 ± 0.115 0.752 ± 0.117 0.379
LNM    0.053
  Positive 19 23  
  Negative 67 40  
  1. NAT + RH Neoadjuvant therapy followed by radical hysterectomy; CCRT Concurrent chemoradiation; SCC-Ag Squamous cell carcinoma antigen; MDT Maximum tumor diameter; LNM Lymph node metastasis; MDT is in unit of mm, SCC-Ag is in unit of ng/ml